APOE and Alzheimer disease: Decreasing lipidation of apoE decreases binding to Aβ and abolishes the isoform difference in Aβ binding, while clearing non-lipidated apoE using specific antibodies suppresses amyloid aggregation in AD mouse models [167, 168].